Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
about
Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencingThe gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytesKorean red ginseng slows depletion of CD4 T cells in human immunodeficiency virus type 1-infected patientsThe human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1.Valproic acid and HIV-1 latency: beyond the sound bite.Impaired 2',3'-dideoxy-3'-thiacytidine accumulation in T-lymphoblastoid cells as a mechanism of acquired resistance independent of multidrug resistant protein 4 with a possible role for ATP-binding cassette C11Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infectionCounterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator TatResidual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cellsContribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infectionDual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissueExpression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acidLatent reservoirs of HIV: obstacles to the eradication of virusA stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected childrenCofilin activation in peripheral CD4 T cells of HIV-1 infected patients: a pilot studyPRMT6 diminishes HIV-1 Rev binding to and export of viral RNAHuman immunodeficiency virus type 1 (HIV-1) proviral DNA load in purified CD4+ cells by LightCycler real-time PCR.Granulocyte-macrophage colony-stimulating factor as an immune-based therapy in HIV infection.Characterization of two candidate genes, NCoA3 and IRF8, potentially involved in the control of HIV-1 latency.Different patterns of HIV-1 DNA after therapy discontinuation.Latency: the hidden HIV-1 challenge.Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual questionTargeting the latent reservoir to achieve functional HIV cureHow to Define the Latent Reservoir: Tools of the TradeChallenges and Opportunities for T-Cell-Mediated Strategies to Eliminate HIV ReservoirsDesigning and Interpreting Limiting Dilution Assays: General Principles and Applications to the Latent Reservoir for Human Immunodeficiency Virus-1Impact of Chromatin on HIV ReplicationHow does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs?HIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategiesRedefining the viral reservoirs that prevent HIV-1 eradicationImmunovirological parameters and cytokines in HIV infectionNew assays for monitoring residual HIV burden in effectively treated individualsHIV-1 eradication strategies: design and assessmentCombinatorial RNA-based gene therapy for the treatment of HIV/AIDSDeveloping Combined HIV Vaccine Strategies for a Functional CureNeurologic complications of HIV-1 infection and its treatment in the era of antiretroviral therapyThe immunological synapse: the gateway to the HIV reservoirRecent developments in human immunodeficiency virus-1 latency researchOrigin of the transmitted virus in HIV infection: infected cells versus cell-free virusIncomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutions
P2860
Q24294385-7C47ECD7-02B1-411A-8BCF-68A5C5AF57A6Q24302212-40726487-0A0F-42EA-ADB7-7E705C10CC15Q24521463-29A9B61C-B3DC-48E6-806B-7966B2C66939Q24525309-F441876A-96BD-4E87-909F-192FC16CF561Q24530234-CF7437C8-CA87-463E-AB09-1FE1842B1382Q24534863-C1F2432D-FC27-4344-9348-A849C90D5F3DQ24536249-FFA2878A-0DB1-477F-A7DD-915C2614DF38Q24537275-CA5ED352-AE67-4245-941C-A766A6B81124Q24548940-F066D806-F07A-4F5B-880B-B378FFEFDD0AQ24550678-72BEF49B-BD1A-4A68-9061-5753A462577CQ24562082-8A386E21-F1F1-4651-9699-C55B1E53BC1DQ24596282-959F9BF1-415A-484B-977A-1369F10FD042Q24615570-45484164-FA0A-4C06-82C8-756F3E9D3E1DQ24620746-5685F981-B3A9-4EE2-A91F-08432DD53981Q24645950-EB74A38C-2F91-4700-8802-7E548763886CQ24684168-66161A38-4FC2-41BA-A7C1-09EB4E0AA60DQ24811629-0CEF24C4-D01B-4302-B8C4-436593BD03FBQ24814373-7B84F3BC-387B-4618-BA53-2A24AE00C666Q24815984-074DE017-3BF7-4B81-822C-4D1B288B0438Q24816681-98E6FAA9-45E3-4686-B1DE-9CC8A89A1005Q25255905-DEB2F632-8051-495E-8ABB-BE87367AD979Q26741384-40B32AC4-DA73-465D-A7AF-209CB405BE63Q26745923-CA0C54C8-F91B-4938-9B27-6037F78CD3CAQ26766705-D2D165BA-9EFC-4578-98B7-654B6C43C40AQ26781511-E8F6B7DF-86A7-4E63-B245-C7B9F19A3BE4Q26781918-A97C62D7-205F-4C6B-A0C0-81F3911243F3Q26782046-0B90FC7F-02D0-4D82-BFD9-0226B990594AQ26822422-2C7EEA3C-35A3-4DB3-8DEF-298A4BB2282CQ26825087-A5D867DC-69C3-49A8-8493-4A0C2FE65683Q26827255-2AC5F450-53E5-4122-BB8C-C4648BD92478Q26829264-85248FC8-2BBC-4A5D-8123-171F6CDAFE2FQ26863589-4B3CE0F2-06B8-4905-8398-BBD70F3F742EQ26864933-C41373F6-17A3-40E6-A1F3-7E9BE717D310Q26866145-9D2B66E3-CE7A-4B49-AB36-19ADEC15F923Q26998898-6CA56EE4-558C-4A6E-9CD8-39A873B9C4E7Q27000422-2AEEE72D-12CF-4DCB-A114-FF5378A899ABQ27002959-B0369FF4-5073-4E5B-8B20-8E2685C31136Q27013114-67A967D6-266B-4A63-ABA8-1510AF337F98Q27021279-B38AA239-2EBE-4028-A440-3E1041ED3286Q27021524-C0A1922B-2E9D-49D4-AAD0-F48F6D5457A7
P2860
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
description
1997 nî lūn-bûn
@nan
1997 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Identification of a reservoir ...... active antiretroviral therapy
@ast
Identification of a reservoir ...... active antiretroviral therapy
@en
Identification of a reservoir ...... active antiretroviral therapy
@nl
type
label
Identification of a reservoir ...... active antiretroviral therapy
@ast
Identification of a reservoir ...... active antiretroviral therapy
@en
Identification of a reservoir ...... active antiretroviral therapy
@nl
prefLabel
Identification of a reservoir ...... active antiretroviral therapy
@ast
Identification of a reservoir ...... active antiretroviral therapy
@en
Identification of a reservoir ...... active antiretroviral therapy
@nl
P2093
P3181
P1433
P1476
Identification of a reservoir ...... active antiretroviral therapy
@en
P2093
D D Richman
J Margolick
K Chadwick
L M Carruth
M Hermankova
M Markowitz
P304
P3181
P356
10.1126/SCIENCE.278.5341.1295
P407
P577
1997-11-14T00:00:00Z